It’s been nearly 20 years since the US Pharmacopeia (USP) established our laboratories in Hyderabad and we began growing our team of scientists and other professionals in India. In the time since, the global pharmaceutical landscape has undergone a tremendous amount of evolution.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.
Anthony Lakavage, Senior Vice President, USP Global External Affairs, shares insights on USP–India's 10th Anniversary and how USP is working globally to increase its impact on improving the quality of medicines, dietary supplements and foods worldwide.
India is a prominent player in today’s global pharmaceutical arena and a major contributor to the world’s supply of medicines. A large number of generics and OTC medicines in the U.S. are imported from India, which makes USP's collaborations with Indian pharma critical.
